PH27511A - Selective adenosine receptor agents - Google Patents

Selective adenosine receptor agents

Info

Publication number: PH27511A
Authority: PH; Philippines
Prior art keywords: adenosine receptor; selective adenosine; receptor agents; agents; selective
Prior art date: 1990-03-26

Application number

PH42193A

Other languages

English (en)

Inventor

Norton P Peet

Nelson L Lentz

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-03-26

Filing date

1991-03-22

Publication date

1993-08-18

1991-03-22 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1993-08-18 Publication of PH27511A publication Critical patent/PH27511A/en

Links

102000009346 Adenosine receptors Human genes 0.000 title 1
108050000203 Adenosine receptors Proteins 0.000 title 1
239000003795 chemical substances by application Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PH42193A 1990-03-26 1991-03-22 Selective adenosine receptor agents PH27511A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/499,111 US5047534A (en)	1990-03-26	1990-03-26	Selective adenosine receptor agents

Publications (1)

Publication Number	Publication Date
PH27511A true PH27511A (en)	1993-08-18

Family

ID=23983864

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH42193A PH27511A (en)	1990-03-26	1991-03-22	Selective adenosine receptor agents

Country Status (22)

Country	Link
US (1)	US5047534A (no)
EP (1)	EP0449175B1 (no)
JP (1)	JP3181305B2 (no)
KR (1)	KR100195368B1 (no)
CN (1)	CN1032815C (no)
AR (1)	AR247887A1 (no)
AT (1)	ATE156130T1 (no)
AU (1)	AU632914B2 (no)
CA (1)	CA2038747C (no)
DE (1)	DE69127010T2 (no)
DK (1)	DK0449175T3 (no)
ES (1)	ES2107431T3 (no)
FI (1)	FI98461C (no)
GR (1)	GR3025135T3 (no)
HU (1)	HU208824B (no)
IE (1)	IE910982A1 (no)
IL (1)	IL97656A (no)
NO (1)	NO177591C (no)
NZ (1)	NZ237484A (no)
PH (1)	PH27511A (no)
PT (1)	PT97133B (no)
ZA (1)	ZA912038B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5208240A (en) *	1991-03-12	1993-05-04	Merrell Dow Pharmaceuticals Inc.	8-substituted purines as selective adenosine receptor agents
JP2928386B2 (ja) *	1992-07-08	1999-08-03	協和醗酵工業株式会社	うつ病治療剤
CA2155130C (en) *	1993-02-26	1994-09-01	Janice M Hitchcock	Xanthine derivatives as adenosine a1 receptor antagonists
WO1994025462A1 (en) *	1993-05-03	1994-11-10	The United States Of America, Represented By The	8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
JPH08509977A (ja) *	1993-05-06	1996-10-22	メレルダウファーマスーティカルズインコーポレイテッド	選択的アデノシン受容体剤としての８−置換キサンチン類
US5629298A (en) *	1995-03-13	1997-05-13	University Of Massachusetts Medical Center	Adenosine as a positive inotrop in the compromised heart
GB9819382D0 (en)	1998-09-04	1998-10-28	Cerebrus Ltd	Chemical compounds I
US6258794B1 (en)	1999-12-14	2001-07-10	The Mclean Hospital Corporation	Treatment of mental conditions including depression
US8202869B2 (en)	2003-06-10	2012-06-19	Kyowa Hakko Kirin Co., Ltd.	Method of treating an anxiety disorder
WO2007036491A1 (de) *	2005-09-30	2007-04-05	Basf Aktiengesellschaft	Verfahren zur herstellung von alpha-substituierten carbonsäuren
US7592461B2 (en) *	2005-12-21	2009-09-22	Bristol-Myers Squibb Company	Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1435916A (en) *	1972-05-11	1976-05-19	Beecham Group Ltd	Pharmaceutical weight-reducing compositions
SE416810C (sv) *	1977-10-14	1982-07-19	Draco Ab	Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
JPS57198544A (en) *	1981-05-28	1982-12-06	Sony Corp	Manufacture of magnetic recording medium
US4593095A (en) *	1983-02-18	1986-06-03	The Johns Hopkins University	Xanthine derivatives
US4772607A (en) *	1986-05-20	1988-09-20	Warner-Lambert Company	Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4783530A (en) *	1986-11-13	1988-11-08	Marion Laboratories, Inc.	8-arylxanthines
DE8817122U1 (de) *	1988-12-22	1993-02-04	Boehringer Ingelheim Kg, 55218 Ingelheim	Neue Xanthinderivate mit Adenosinantogenistischer Wirkung

1990
- 1990-03-26 US US07/499,111 patent/US5047534A/en not_active Expired - Fee Related
1991
- 1991-03-19 NZ NZ237484A patent/NZ237484A/xx unknown
- 1991-03-19 AU AU73537/91A patent/AU632914B2/en not_active Ceased
- 1991-03-19 ZA ZA912038A patent/ZA912038B/xx unknown
- 1991-03-20 AR AR91319262A patent/AR247887A1/es active
- 1991-03-21 CA CA002038747A patent/CA2038747C/en not_active Expired - Fee Related
- 1991-03-22 IL IL9765691A patent/IL97656A/en not_active IP Right Cessation
- 1991-03-22 PH PH42193A patent/PH27511A/en unknown
- 1991-03-25 HU HU91985A patent/HU208824B/hu not_active IP Right Cessation
- 1991-03-25 NO NO911200A patent/NO177591C/no not_active IP Right Cessation
- 1991-03-25 FI FI911420A patent/FI98461C/fi active
- 1991-03-25 AT AT91104668T patent/ATE156130T1/de not_active IP Right Cessation
- 1991-03-25 PT PT97133A patent/PT97133B/pt not_active IP Right Cessation
- 1991-03-25 EP EP91104668A patent/EP0449175B1/en not_active Expired - Lifetime
- 1991-03-25 KR KR1019910004660A patent/KR100195368B1/ko not_active Expired - Fee Related
- 1991-03-25 IE IE098291A patent/IE910982A1/en not_active IP Right Cessation
- 1991-03-25 ES ES91104668T patent/ES2107431T3/es not_active Expired - Lifetime
- 1991-03-25 CN CN91101892A patent/CN1032815C/zh not_active Expired - Fee Related
- 1991-03-25 DE DE69127010T patent/DE69127010T2/de not_active Expired - Fee Related
- 1991-03-25 DK DK91104668.8T patent/DK0449175T3/da active
- 1991-03-26 JP JP08451291A patent/JP3181305B2/ja not_active Expired - Fee Related
1997
- 1997-10-22 GR GR970402767T patent/GR3025135T3/el unknown

Also Published As

Publication number	Publication date
CN1032815C (zh)	1996-09-18
NO177591C (no)	1995-10-18
FI98461B (fi)	1997-03-14
ES2107431T3 (es)	1997-12-01
HU208824B (en)	1994-01-28
PT97133A (pt)	1991-12-31
CA2038747C (en)	2002-05-28
FI911420L (fi)	1991-09-27
EP0449175B1 (en)	1997-07-30
US5047534A (en)	1991-09-10
KR100195368B1 (ko)	1999-06-15
IE910982A1 (en)	1991-10-09
KR910016752A (ko)	1991-11-05
CA2038747A1 (en)	1991-09-27
JPH04221384A (ja)	1992-08-11
FI911420A0 (fi)	1991-03-25
HUT56570A (en)	1991-09-30
NZ237484A (en)	1993-10-26
IL97656A0 (en)	1992-06-21
CN1055181A (zh)	1991-10-09
NO177591B (no)	1995-07-10
DE69127010T2 (de)	1997-11-13
EP0449175A3 (en)	1993-01-20
EP0449175A2 (en)	1991-10-02
NO911200L (no)	1991-09-27
ATE156130T1 (de)	1997-08-15
AU7353791A (en)	1991-10-03
AU632914B2 (en)	1993-01-14
NO911200D0 (no)	1991-03-25
PT97133B (pt)	1998-07-31
DE69127010D1 (de)	1997-09-04
ZA912038B (en)	1991-12-24
FI98461C (fi)	1997-06-25
IL97656A (en)	1996-06-18
JP3181305B2 (ja)	2001-07-03
GR3025135T3 (en)	1998-02-27
DK0449175T3 (da)	1998-02-23
AR247887A1 (es)	1995-04-28

Publication	Publication Date	Title
HU9300964D0 (en)	1993-06-28	Nucleoside derivatives
ZA89440B (en)	1990-01-31	Dideoxydidehydrocarbocyclic nucleosides
OA09677A (en)	1993-05-15	Nucleoside derivatives
HU913074D0 (en)	1992-01-28	Fibrinogenic receptor antagonists
GB2217320B (en)	1992-04-08	Dideoxydidehydrocarbocyclic nucleosides
GB2264948B (en)	1996-10-16	Human adenosine receptors
ZA913721B (en)	1992-02-26	Antiviral agents
IL97486A0 (en)	1992-06-21	Neurospora expression system
ZA912038B (en)	1991-12-24	Selective adenosine receptor agents
OA09697A (en)	1993-08-30	Nucleoside derivatives
EP0497988A4 (en)	1993-03-10	Antiviral agent
GB9014194D0 (en)	1990-08-15	Antiparasitic agents
GB9008202D0 (en)	1990-06-13	Cushion
ZA902282B (en)	1990-12-28	Selective adenosine receptor compounds
EP0450102A4 (en)	1992-05-06	Nucleoside derivative
IL106287A0 (en)	1993-11-15	Receptor derivatives
FI955257A7 (fi)	1995-11-02	8-substituoidut-ksantiinit valikoivina adenosiinireseptoriaineina
ZA934873B (en)	1994-01-18	Receptor derivatives
ZA911154B (en)	1992-10-28	Therapeutic nucleosides
GB9110987D0 (en)	1991-07-10	Dideoxydidehydrocarboxyclic nucleosides
EP0539587A4 (en)	1993-07-28	Antiretroviral agent
GB9017922D0 (en)	1990-09-26	Antiparasitic agents
GB9007650D0 (en)	1990-05-30	Nucleoside derivatives
GB9007651D0 (en)	1990-05-30	Nucleoside derivatives
GB8916323D0 (en)	1989-08-31	Nucleosides